Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$26.04 -0.16 (-0.61%)
At close: Oct 22, 2026 · 4:00 PM EDT

Amphastar Pharmaceuticals (AMPH) Consolidated Net Income (2013 - 2026)

Updated

Amphastar Pharmaceuticals (AMPH) posted Consolidated Net Income of $30.35 million for Q2 2026, down 2.2% from $31.03 million a year earlier but up 372.7% from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Consolidated Net Income (2013 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Consolidated Net Income at Amphastar Pharmaceuticals was $78.55 million, down 41.7% year-over-year; for FY2025, it was $98.09 million, down 38.5% from FY2024.

  • Annual Consolidated Net Income shows a five-year compound annual growth rate of 145.6% (FY2020 to FY2025).
  • In prior years, Amphastar Pharmaceuticals' Consolidated Net Income was $159.52 million in FY2024 (+16.0%), $137.55 million in FY2023 (+50.5%), $91.39 million in FY2022 (+44.4%) and $63.3 million in FY2021.
  • Quarterly Consolidated Net Income has run from a low of $6.42 million in Q1 2026 to a high of $49.22 million in Q3 2023 over five years.
  • On a year-over-year basis, Consolidated Net Income has declined in each of the last six quarters, with an average decline of 30.3% over the last eight quarters.
  • The strongest year-over-year quarter for Consolidated Net Income in the past five years was Q3 2021, with growth of 545.9%; the weakest was Q1 2026, with a decline of 74.6%.
  • According to Business Quant data, Consolidated Net Income for the three prior quarters was $6.42 million (Q1 2026), $24.43 million (Q4 2025) and $17.35 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 210.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 3.62 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 2.51 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -10.50 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -237.00 Mn
10 Amphastar Pharmaceuticals 1.14 Bn -3.30 Mn 93.47 Mn 30.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.35 Mn
Mar 31, 2026 6.42 Mn
Dec 31, 2025 24.43 Mn
Sep 30, 2025 17.35 Mn
Jun 30, 2025 31.03 Mn
Mar 31, 2025 25.29 Mn
Dec 31, 2024 37.96 Mn
Sep 30, 2024 40.43 Mn
Jun 30, 2024 37.95 Mn
Mar 31, 2024 43.18 Mn
Dec 31, 2023 36.17 Mn
Sep 30, 2023 49.22 Mn
Jun 30, 2023 26.12 Mn
Mar 31, 2023 26.03 Mn
Dec 31, 2022 33.91 Mn
Sep 30, 2022 15.87 Mn
Jun 30, 2022 17.35 Mn
Mar 31, 2022 24.25 Mn
Dec 31, 2021 19.76 Mn
Sep 30, 2021 30.96 Mn
API Access

Amphastar Pharmaceuticals Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=AMPH&period=max&api_key=YOUR_API_KEY